• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭与心房颤动:流行病学、病理生理学及诊断的相互关系

Heart failure with preserved ejection fraction and atrial fibrillation: epidemiology, pathophysiology, and diagnosis interplay.

作者信息

Kittipibul Veraprapas, Lam Carolyn S P

机构信息

Duke Clinical Research Institute, Durham, NC, USA.

Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.

出版信息

Heart Fail Rev. 2025 Jan 24. doi: 10.1007/s10741-025-10488-0.

DOI:10.1007/s10741-025-10488-0
PMID:39849281
Abstract

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are increasingly prevalent cardiovascular conditions, particularly among the elderly population. These two conditions share common risk factors and often coexist, leading to a complex interplay that alters the clinical course of each other. The pathophysiology of HFpEF is multifaceted and intricately linked, with atrial disease serving as a common pathophysiological pathway. Diagnosis of HFpEF in the setting of AF, and vice versa, can be challenging; thus, effective screening and diagnostic strategies are needed. Understanding the complex relationship between HFpEF and AF is crucial for optimal patient management by timely disease recognition and identification of therapeutic interventions or treatment strategies.

摘要

射血分数保留的心力衰竭(HFpEF)和心房颤动(AF)是日益普遍的心血管疾病,在老年人群中尤为常见。这两种疾病有共同的危险因素,且常同时存在,导致复杂的相互作用,改变彼此的临床病程。HFpEF的病理生理学是多方面且错综复杂地相互关联的,心房疾病是常见的病理生理途径。在AF背景下诊断HFpEF,反之亦然,可能具有挑战性;因此,需要有效的筛查和诊断策略。了解HFpEF和AF之间的复杂关系对于通过及时识别疾病和确定治疗干预措施或治疗策略来实现最佳患者管理至关重要。

相似文献

1
Heart failure with preserved ejection fraction and atrial fibrillation: epidemiology, pathophysiology, and diagnosis interplay.射血分数保留的心力衰竭与心房颤动:流行病学、病理生理学及诊断的相互关系
Heart Fail Rev. 2025 Jan 24. doi: 10.1007/s10741-025-10488-0.
2
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.射血分数保留的心力衰竭与心房颤动:罪恶双生子。
J Am Coll Cardiol. 2016 Nov 15;68(20):2217-2228. doi: 10.1016/j.jacc.2016.08.048.
3
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.心房颤动引发心力衰竭,反之亦然:射血分数保留与降低时的时间关联及差异
Circulation. 2016 Feb 2;133(5):484-92. doi: 10.1161/CIRCULATIONAHA.115.018614. Epub 2016 Jan 8.
4
Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.心房颤动和射血分数保留的心力衰竭:来自美国全国代表性队列的独特临床表型的见解。
Int J Cardiol. 2018 Sep 1;266:112-118. doi: 10.1016/j.ijcard.2018.02.007.
5
Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.射血分数保留与降低的心衰伴房颤患者卒中及血栓栓塞风险的系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):495. doi: 10.1186/s12872-024-04133-1.
6
Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction.心房颤动是射血分数保留的心力衰竭患者心力衰竭住院的独立危险因素。
ESC Heart Fail. 2022 Oct;9(5):2918-2927. doi: 10.1002/ehf2.13836. Epub 2022 Jun 16.
7
Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction.非心血管合并症在心房颤动和射血分数保留的心力衰竭中的重要性。
ESC Heart Fail. 2025 Feb;12(1):389-400. doi: 10.1002/ehf2.15093. Epub 2024 Sep 21.
8
Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.心房颤动患者心力衰竭表型的患病率和结局。
Int J Cardiol. 2024 Oct 1;412:132320. doi: 10.1016/j.ijcard.2024.132320. Epub 2024 Jul 2.
9
Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.射血分数保留的心力衰竭伴心房颤动患者的心房功能障碍。
J Am Coll Cardiol. 2020 Sep 1;76(9):1051-1064. doi: 10.1016/j.jacc.2020.07.009.
10
Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.射血分数降低与保留型心力衰竭所致心房颤动:死亡及不良结局的系统评价与荟萃分析
Int J Cardiol. 2016 Jan 15;203:660-6. doi: 10.1016/j.ijcard.2015.10.220. Epub 2015 Oct 28.

引用本文的文献

1
Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.射血分数保留的心力衰竭患者中盐皮质激素受体拮抗剂:一项系统评价和荟萃分析。
J Clin Med. 2025 May 21;14(10):3598. doi: 10.3390/jcm14103598.
2
TQCPat: Tree Quantum Circuit Pattern-based Feature Engineering Model for Automated Arrhythmia Detection using PPG Signals.TQCPat:基于树量子电路模式的特征工程模型,用于利用光电容积脉搏波信号自动检测心律失常
J Med Syst. 2025 Mar 24;49(1):38. doi: 10.1007/s10916-025-02169-0.

本文引用的文献

1
Heart Failure with Preserved Ejection Fraction Correlates with Fibrotic Atrial Myopathy in Patients Undergoing Atrial Fibrillation Ablation.射血分数保留的心力衰竭与接受心房颤动消融术患者的纤维化心房肌病相关。
J Clin Med. 2024 Sep 24;13(19):5685. doi: 10.3390/jcm13195685.
2
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.《2024年心力衰竭统计数据:美国心力衰竭学会2024年更新报告》
J Card Fail. 2025 Jan;31(1):66-116. doi: 10.1016/j.cardfail.2024.07.001. Epub 2024 Sep 24.
3
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
2024年欧洲心脏病学会(ESC)心房颤动管理指南,与欧洲心胸外科学会(EACTS)联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
4
Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.心房颤动患者心力衰竭表型的患病率和结局。
Int J Cardiol. 2024 Oct 1;412:132320. doi: 10.1016/j.ijcard.2024.132320. Epub 2024 Jul 2.
5
Atrial fibrillation burden: a new outcome predictor and therapeutic target.房颤负担:一个新的预后预测因子和治疗靶点。
Eur Heart J. 2024 Aug 16;45(31):2824-2838. doi: 10.1093/eurheartj/ehae373.
6
Diagnosing diastolic dysfunction and heart failure with preserved ejection fraction in patients with atrial fibrillation: a clinical challenge.诊断心房颤动患者舒张功能障碍和射血分数保留型心力衰竭:临床挑战。
Eur Heart J Cardiovasc Imaging. 2024 Oct 30;25(11):1546-1553. doi: 10.1093/ehjci/jeae160.
7
Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation.激烈辩论:设备检测到的亚临床房颤应与临床房颤同等对待。
Eur Heart J. 2024 Aug 3;45(29):2594-2603. doi: 10.1093/eurheartj/ehae365.
8
Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF.在心房颤动中筛查未被识别的射血分数保留型心力衰竭,以及在射血分数保留型心力衰竭中筛查未被识别的心房颤动。
JACC Heart Fail. 2024 Jun;12(6):990-998. doi: 10.1016/j.jchf.2024.04.010.
9
Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum.心房颤动与射血分数谱心力衰竭患者报告结局的相关性。
Am Heart J. 2024 Jul;273:61-71. doi: 10.1016/j.ahj.2024.04.017. Epub 2024 Apr 27.
10
Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.心房颤动与射血分数降低、轻度降低和保留的心衰不良结局风险:系统评价和荟萃分析。
J Cardiovasc Electrophysiol. 2024 Apr;35(4):715-726. doi: 10.1111/jce.16209. Epub 2024 Feb 13.